Rare case of malignant transformation of recurrent respiratory papillomatosis associated with human papillomavirus type 6 infection and p53 overexpression

[1]  R. Wu,et al.  Constitutive Overexpression of the Oncogene Racl in the Airway of Recurrent Respiratory Papillomatosis Patients Is a Targetable Host-Susceptibility Factor , 2012, Molecular medicine.

[2]  H. Becker,et al.  Recurrent Respiratory Papillomatosis: A Rare Chronic Disease, Difficult to Treat, with Potential to Lung Cancer Transformation: Apropos of Two Cases and a Brief Literature Review , 2011, Case Reports in Oncology.

[3]  R. Ossoff,et al.  Natural Progression of Dysplasia in Adult Recurrent Respiratory Papillomatosis , 2011, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[4]  Y. Song,et al.  Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment. , 2010, Biochemical pharmacology.

[5]  S. Zeitels,et al.  Malignant transformation of a highly aggressive human papillomavirus type 11-associated recurrent respiratory papillomatosis. , 2010, American journal of otolaryngology.

[6]  Y. Song,et al.  Presence of HPV type 6 in dysplasia and carcinoma arising from recurrent respiratory papillomatosis , 2009, Head & neck.

[7]  C. Derkay,et al.  Pharmacotherapy of recurrent respiratory papillomatosis: an expert opinion. , 2009, Expert opinion on pharmacotherapy.

[8]  Matthew M. McIntosh.  MALIGNANT TRANSFORMATION IN RECURRENT RESPIRATORY PAPILLOMATOSIS , 2008 .

[9]  S. Coniglio,et al.  Up-regulation of Rac1 by Epidermal Growth Factor Mediates COX-2 Expression in Recurrent Respiratory Papillomas , 2007, Molecular medicine.

[10]  O. Guntinas-Lichius,et al.  Long-term results of surgical treatment for recurrent respiratory papillomatosis , 2007, Acta oto-laryngologica.

[11]  Nadine Shehab,et al.  Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis: A Review of the Literature , 2005, Pharmacotherapy.

[12]  V. Gerein,et al.  Incidence, age at onset, and potential reasons of malignant transformation in recurrent respiratory papillomatosis patients: 20 years experience , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[13]  J. Field,et al.  Integration of Human Papillomavirus Type 11 in Recurrent Respiratory Papilloma‐Associated Cancer , 2004, The Laryngoscope.

[14]  M. Schwartz,et al.  Molecular Transformation of Recurrent Respiratory Papillomatosis: Viral Typing and P53 Overexpression , 2003, The Annals of otology, rhinology, and laryngology.

[15]  K. Götte,et al.  Current advances in the basic research and clinical management of juvenile-onset recurrent respiratory papillomatosis , 2000, European Archives of Oto-Rhino-Laryngology.

[16]  D. Kimberlin,et al.  Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy. , 2000, Antiviral research.

[17]  S. Heffelfinger,et al.  Expression of Ki-67, tumor suppressor proteins, growth factor, and growth factor receptor in juvenile respiratory papillomatosis: Ki-67 and p53 as predictors of aggressive disease. , 1997, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[18]  S. Tyring,et al.  Malignant Transformation of Recurrent Respiratory Papillomatosis Associated With Integrated Human Papillomavirus Type 11 DNA and Mutation of p53 , 1998, The Laryngoscope.

[19]  J. Betka,et al.  Laryngeal papilloma--precancerous condition? , 1997, Acta oto-laryngologica. Supplementum.